The Ensign Group, Inc. (ENSG) is a publicly traded Healthcare sector company. As of May 21, 2026, ENSG trades at $176.83 with a market cap of $10.32B and a P/E ratio of 29.64. ENSG moved +1.33% today. Year to date, ENSG is +0.99%; over the trailing twelve months it is +19.52%. Its 52-week range spans $118.73 to $218.00. Analyst consensus is buy with an average price target of $218.50. Rallies surfaces ENSG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Ensign Group drops after Q1 revenue miss despite raised 2026 outlook: The Ensign Group shares fell as investors reacted to Q1 2026 results that topped EPS expectations but came in light on revenue. The pullback is hitting a stock that has been trading at premium valuations after a long run-up, amplifying sensitivity to any top-line miss.
| Metric | Value |
|---|---|
| Price | $176.83 |
| Market Cap | $10.32B |
| P/E Ratio | 29.64 |
| EPS | $6.00 |
| Dividend Yield | 0.07% |
| 52-Week High | $218.00 |
| 52-Week Low | $118.73 |
| Volume | 10 |
| Avg Volume | 0 |
| Revenue (TTM) | $5.06B |
| Net Income | $344.26M |
| Gross Margin | 20.54% |
3 analysts cover ENSG: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $218.50.